Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.745 USD | -0.19% | +10.17% | +29.85% |
05-07 | Cogent Biosciences Q1 Loss Widens | MT |
05-07 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.85% | 742M | |
+3.60% | 106B | |
+7.02% | 23.47B | |
-14.70% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.74% | 16.78B | |
+4.99% | 14.41B | |
+35.84% | 12.86B | |
+323.59% | 8.78B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- JPMorgan Chase Starts Coverage on Cogent Biosciences with Overweight Rating, $18 Price Target